This research focuses on the antimicrobial activity of the mouse chemokine CCL28. In addition to their well characterized chemotactic activity, many chemokines have been shown to be antimicrobial in vitro, including the mucosally expressed chemokine CCL28. I have investigated the primary sequence features required for antimicrobial activity, salt sensitive nature of killing/binding mechanism, and in vivo microbial interactions of CCL28. Through the use of protein mutation and expression techniques, I have shown that the holoprotein (108 amino acids) is necessary for full antimicrobial activity of CCL28. Furthermore, the C terminal region of CCL28 is essential for microbial killing as an almost complete loss of antimicrobial activity is seen following the removal of the C terminal 24 amino acids. The positively charged amino acids of the C-terminus directly contributed to the antimicrobial activity of CCL28. These experiments are the first to investigate the role of primary structure on the killing activity of an antimicrobial chemokine. Using flow cytometry analysis, I found that the salt-sensitive nature of CCL28 killing activity corresponds to its binding ability. Additionally, I have shown direct evidence for in vivo interaction between commensal bacteria and endogenously expressed CCL28 in the mouse large intestine. This interaction may directly correlate to the in vivo antimicrobial activity of CCL28. Lastly, I have begun to generate a CCL28 knockout mouse model to directly address the in vivo antimicrobial activity of CCL28. Vector construction and ES cell targeting by the vector has been completed, chimeric mouse generation remains to be done. This work represents the first systematic study of antimicrobial chemokine function. This work extends our understanding of antimicrobial proteins and their role in innate immune protection of the host and provides guidance for making better alternative antimicrobials.

RfaH is a unique bacterial protein that enhances transcription of a select group of long operons in many Gram-negative bacteria. Operons regulated by RfaH possess an upstream operon polarity suppressor sequence, which recruits the RfaH protein to the RNA polymerase during transcription of genes, most of which are involved in the synthesis of cell-surface features. These include synthesis of the lipopolysaccharide (LPS) core and O-antigen in Salmonella and Escherichia coli, as well as F-plasmid conjugation pilus and capsule in E. coli. LPS is an important virulence factor in many Gram-negative bacteria, and protects Y. pseudotuberculosis against host antimicrobial chemokines. Recently published high-throughput transposon mutant screens have also suggested a role for RfaH in the ability of Y. pseudotuberculosis to colonize mice. However, the role of RfaH in Y. pseudotuberculosis and its descendent Yersinia pestis has not been carefully examined. In these studies we investigated the effect RfaH has on the structure of the LPS in both species at different temperatures. We also identified LPS-synthesis related genes that are regulated by RfaH. We determined the effect of RfaH on bacterial resistance to host defense peptides, and the ability of Y. pseudotuberculosis to colonize mice. We found that the loss of the rfaH gene had different effects in Y. pseudotuberculosis and Y. pestis. Loss of rfaH caused a truncation in the core region in Y. pseudotuberculosis strain IP32953 at both 21°C and 37°C, but only at 37°C in Y. pestis strain KIM6+. Similarly, we found that transcription of individual genes that are predicted to function in core or O-antigen synthesis were downregulated in the rfaH mutant strains in both species, but the impact of rfaH deletion was greater in Y. pseudotuberculosis. When tested for their ability to survive in the presence of antimicrobial peptides, the Y. pseudotuberculosis rfaH deficient bacteria were much more susceptible than wild-type to killing by polymyxin and by the antimicrobial chemokine CCL28. However, the Y. pestis rfaH mutant strain was equally susceptible to CCL28 as the wild-type strain. Infection of mice with Y. pseudotuberculosis show that rfaH deficient bacteria were able to survive as effectively as the wild-type following oral or intravenous inoculation, with or without the pYV virulence plasmid. Overall, our results show that while RfaH controls LPS gene expression in both Y. pseudotuberculosis and Y. pestis, its impact is much greater in Y. pseudotuberculosis. Furthermore, although loss of rfaH greatly reduces the ability of Y. pseudotuberculosis to resist antimicrobial peptides, it is not required for virulence in this species.

Infants are born with naive immune systems, making them susceptible to a variety of infections. In order to protect the newborn infant it is important that mothers be able to pass protective IgA antibodies to their infants through breast milk. B cells that produce IgA enter the mammary tissue during lactation and secrete IgA into the milk. During pregnancy, the mammary tissue expresses high levels of chemokines, molecules that allow lymphocytes to selectively home to specific tissues. The chemokine CCL28 has been shown to be upregulated during both pregnancy and lactation, and is vital for the ability of IgA-producing B cells to home to the mammary tissue during lactation. The aim of this study was to determine whether CCL28 expression is regulated by prolactin signaling.

The mucosal system, which forms a barrier between internal organ systems and the external environment, is frequently exposed to pathogenic microorganisms. Immunoglobulin A (IgA) antibody secreting cells (ASCs) localize in the lamina propria, and produce IgA antibodies which help protect mucosal tissues. The concept of a common mucosal immune system in which IgA ASCs have the ability to populate any mucosal site has been proposed (1, 2). However, recent research has suggested that IgA ASCs primed in different mucosal sites might possess different sets of chemokine receptors, and therefore migrate specifically to particular mucosal locations (3). In this study, the specific compartmentalization of IgA ASCs in two mouse salivary glands: sublingual gland (SLG), and submandibular gland (SMG) was studied. It was observed that SLG had 12 times more IgA ASCs per gram of gland than that of SMG (p<0.01). This suggested that IgA ASCs migrated to the two salivary glands with different efficiencies. Since the migration of lymphocytes is mediated by interactions between tissue specific chemokines and chemokine receptors, I hypothesized that the specific compartmentalization of IgA ASCs in the SLG and SMG was mediated by the differential expression of IgA ASC attracting chemokines. Quantitative PCR was used and showed that SLG expressed high levels of CCL28 and its receptor CCR10, which correlated to the distribution of IgA ASCs in the two salivary glands. In agreement with QPCR data, reduced levels of IgA ASCs were found in the SLG of CCR10 deficient mice when compared to wild type (WT) mice. Adoptive transfer of CCR10 deficient mice with WT spleen cells reconstituted the WT phenotype. It was therefore concluded that the interaction between CCL28 and CCR10 play an important role in mediating the migration of IgA ASCs into SLG. These results suggested that the accumulation of IgA ASC to distinct salivary glands is a highly selective process. These data also suggested that homing within mucosal sites is not common but rather a highly regulated process with specific subsets of cells homing to different tissues within the mucosal immune system.